Evidence map›Paper›PMID 28258062›Full record

ArticleThe EMBO journal2017

The linear ubiquitin chain assembly complex regulates TRAIL-induced gene activation and cell death.

Elodie Lafont, Chahrazade Kantari-Mimoun, Peter Draber, Diego De Miguel, Torsten Hartwig, Matthias Reichert, Sebastian Kupka, Yutaka Shimizu, Lucia Taraborrelli, Maureen Spit and 2 more

Open access · hybridAbstract read
In one paragraph

Article in The EMBO journal, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 72 papers.

0numbers the graph read from it
0cells of the map it votes in
72citing papers in PubMed
6.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

72 citing papers in PubMed, 106 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Pharmacological targeting of caspase-8/c-FLIPCommunications biology · 2025
    Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. E3 ubiquitin ligase geneFrontiers in immunology · 2024
    Review
  18. Article
  19. Review
  20. Review

12 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 2 countries.

Elodie LafontCentre for Cell Death, Cancer and Inflammation (CCCI), UCL Cancer Institute, University College London, London, UK.
Chahrazade Kantari-MimounCentre for Cell Death, Cancer and Inflammation (CCCI), UCL Cancer Institute, University College London, London, UK.
Peter DraberCentre for Cell Death, Cancer and Inflammation (CCCI), UCL Cancer Institute, University College London, London, UK.
Diego De MiguelCentre for Cell Death, Cancer and Inflammation (CCCI), UCL Cancer Institute, University College London, London, UK.
Torsten HartwigCentre for Cell Death, Cancer and Inflammation (CCCI), UCL Cancer Institute, University College London, London, UK.
Matthias ReichertCentre for Cell Death, Cancer and Inflammation (CCCI), UCL Cancer Institute, University College London, London, UK.
Sebastian KupkaCentre for Cell Death, Cancer and Inflammation (CCCI), UCL Cancer Institute, University College London, London, UK.
Yutaka ShimizuCentre for Cell Death, Cancer and Inflammation (CCCI), UCL Cancer Institute, University College London, London, UK.
Lucia TaraborrelliCentre for Cell Death, Cancer and Inflammation (CCCI), UCL Cancer Institute, University College London, London, UK.
Maureen SpitCentre for Cell Death, Cancer and Inflammation (CCCI), UCL Cancer Institute, University College London, London, UK.
Martin R SprickHeidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGMBH), Heidelberg, Germany.
Henning WalczakCentre for Cell Death, Cancer and Inflammation (CCCI), UCL Cancer Institute, University College London, London, UK h.walczak@ucl.ac.uk.ORCID 0000-0002-6312-4591
CRUK Lung Cancer Centre of Excellence · GBGerman Cancer Research Center · DE

Funding

Biotechnology and Biological Sciences Research Council BB/J013129/1Cancer Research UK 17341Cancer Research UK 20265European Research Council 294880Wellcome Trust
6 · The paper itself

Abstract

The linear ubiquitin chain assembly complex (LUBAC) is the only known E3 ubiquitin ligase which catalyses the generation of linear ubiquitin linkages

Indexed as

Cell DeathTranscriptional ActivationCell LineHumansReceptors, TNF-Related Apoptosis-Inducing LigandTNF-Related Apoptosis-Inducing LigandUbiquitin-Protein LigasesReceptors, TNF-Related Apoptosis-Inducing LigandTNF-Related Apoptosis-Inducing LigandTNFSF10 protein, humanUbiquitin-Protein Ligasescell deathLUBACNF‐κBTRAILubiquitin

Identifiers

PMID28258062
PMCPMC5412822
OpenAlexW2594607272

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.